BIOMAT Database Logo BIOMAT Database Logo

[Comparison of the degree of regression of small cell lung neoplasm in clinical-radiologic evaluation with levels of neuron specific enolase (NSE) in serum]. 1995

E Rowińska-Zakrzewska, and M Szturmowicz, and A Sakowicz, and L Pawlicka, and P Remiszewki, and J Szopiński, and E Wiatr, and J Zych
III Kliniki Gruźlicy i Chorób Płuc, Instytutu Gruźlicy i Chorób Płuc w Warszawie.

NSE was estimated using Pharmacia test and radioimmunologic method in the serum of 41 SCLC patients before treatment, at the time of maximal tumor response and in some patients also during progression. The level of 12,5 ng/l was regarded as the upper limit of normal. Elevated NSE levels before treatment were found in 12 out of 20 patients with limited disease and in 19 out of 21 patients with extensive disease. Complete remission (CR) was observed only in patients with limited disease and in those in whom NSE serum level was below 50 ng/l. Elevated NSE serum levels decreased in all those in whom partial remission (PR) or CR of tumor was obtained. Decrease of elevated NSE levels was however also observed in some patients with no significant regression of tumor. The decrease of serum NSE level seemed to be a good prognostic factor even in this last group. NSE serum level increased in 7 out 10 patients where progressive disease after PR was found. In 3 patients however NSE level persisted in normal values despite progression. The significance of this fact was discussed.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008991 Monitoring, Physiologic The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. Patient Monitoring,Monitoring, Physiological,Physiologic Monitoring,Monitoring, Patient,Physiological Monitoring
D010751 Phosphopyruvate Hydratase A hydro-lyase that catalyzes the dehydration of 2-phosphoglycerate to form PHOSPHOENOLPYRUVATE. Several different isoforms of this enzyme exist, each with its own tissue specificity. Enolase,Neuron-Specific Enolase,2-Phospho-D-Glycerate Hydro-Lyase,2-Phospho-D-Glycerate Hydrolase,2-Phosphoglycerate Dehydratase,Enolase 2,Enolase 3,Muscle-Specific Enolase,Nervous System-Specific Enolase,Non-Neuronal Enolase,alpha-Enolase,beta-Enolase,gamma-Enolase,2 Phospho D Glycerate Hydro Lyase,2 Phospho D Glycerate Hydrolase,2 Phosphoglycerate Dehydratase,Dehydratase, 2-Phosphoglycerate,Enolase, Muscle-Specific,Enolase, Nervous System-Specific,Enolase, Neuron-Specific,Enolase, Non-Neuronal,Hydratase, Phosphopyruvate,Hydro-Lyase, 2-Phospho-D-Glycerate,Muscle Specific Enolase,Nervous System Specific Enolase,Neuron Specific Enolase,Non Neuronal Enolase,System-Specific Enolase, Nervous,alpha Enolase,beta Enolase,gamma Enolase
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

E Rowińska-Zakrzewska, and M Szturmowicz, and A Sakowicz, and L Pawlicka, and P Remiszewki, and J Szopiński, and E Wiatr, and J Zych
[Clinical evaluation of serum NSE (neuron specific enolase) levels in cases of small cell lung cancer].
January 1988, Rinsho hoshasen. Clinical radiography,
E Rowińska-Zakrzewska, and M Szturmowicz, and A Sakowicz, and L Pawlicka, and P Remiszewki, and J Szopiński, and E Wiatr, and J Zych
[Serum neuron specific enolase (NSE) levels in patients with non small cell lung cancer].
June 1992, Nihon Kyobu Shikkan Gakkai zasshi,
E Rowińska-Zakrzewska, and M Szturmowicz, and A Sakowicz, and L Pawlicka, and P Remiszewki, and J Szopiński, and E Wiatr, and J Zych
[Serum NSE (neuron-specific enolase) levels in small cell lung cancer, with special reference to the measurement of serial serum NSE levels].
August 1987, Gan to kagaku ryoho. Cancer & chemotherapy,
E Rowińska-Zakrzewska, and M Szturmowicz, and A Sakowicz, and L Pawlicka, and P Remiszewki, and J Szopiński, and E Wiatr, and J Zych
[Serum neuron-specific enolase (NSE) in patients with small cell lung cancer--comparison with carcinoembryonic antigen (CEA)].
January 1987, Gan to kagaku ryoho. Cancer & chemotherapy,
E Rowińska-Zakrzewska, and M Szturmowicz, and A Sakowicz, and L Pawlicka, and P Remiszewki, and J Szopiński, and E Wiatr, and J Zych
Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).
October 1994, British journal of cancer,
E Rowińska-Zakrzewska, and M Szturmowicz, and A Sakowicz, and L Pawlicka, and P Remiszewki, and J Szopiński, and E Wiatr, and J Zych
[Serum neuron-specific enolase (NSE) in patients with primary lung cancer].
April 1988, Rinsho byori. The Japanese journal of clinical pathology,
E Rowińska-Zakrzewska, and M Szturmowicz, and A Sakowicz, and L Pawlicka, and P Remiszewki, and J Szopiński, and E Wiatr, and J Zych
[Clinical evaluation of serum neuron-specific enolase levels in patients with lung cancer].
February 1987, Radioisotopes,
E Rowińska-Zakrzewska, and M Szturmowicz, and A Sakowicz, and L Pawlicka, and P Remiszewki, and J Szopiński, and E Wiatr, and J Zych
Serum neuron specific enolase (NSE) is a determinant of response duration in small cell lung cancer (SCLC).
September 1992, British journal of cancer,
E Rowińska-Zakrzewska, and M Szturmowicz, and A Sakowicz, and L Pawlicka, and P Remiszewki, and J Szopiński, and E Wiatr, and J Zych
[Clinical significance of serum neuron specific enolase (NSE) levels in patients with gastric and colorectal cancer].
November 1986, Rinsho byori. The Japanese journal of clinical pathology,
E Rowińska-Zakrzewska, and M Szturmowicz, and A Sakowicz, and L Pawlicka, and P Remiszewki, and J Szopiński, and E Wiatr, and J Zych
Enzymatic determination of serum neuron-specific enolase in small cell lung cancers. Utility of the serum neuron-specific enolase/serum nonneuronal enolase ratio.
June 1988, Chest,
Copied contents to your clipboard!